Targeted intracellular glucose oxidase nanotherapy enables single-dose treatment of prostate cancer.

Manouchehri S, Fatemipayam N, Singh A, Hanna A, Erfani A, More S, Ranjan A, Ramsey JD

DOI: 10.1016/j.ijpharm.2026.127194
Published: 2026 Sep 5
Container: International journal of pharmaceutics
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijpharm.2026.127194,
  title = {Targeted intracellular glucose oxidase nanotherapy enables single-dose treatment of prostate cancer.},
  author = {Manouchehri S and Fatemipayam N and Singh A and Hanna A and Erfani A and More S and Ranjan A and Ramsey JD},
  year = {2026},
  journal = {International journal of pharmaceutics},
  doi = {10.1016/j.ijpharm.2026.127194},
  url = {https://doi.org/10.1016/j.ijpharm.2026.127194}
}

RIS

TY  - JOUR
TI  - Targeted intracellular glucose oxidase nanotherapy enables single-dose treatment of prostate cancer.
AU  - Manouchehri S
AU  - Fatemipayam N
AU  - Singh A
AU  - Hanna A
AU  - Erfani A
AU  - More S
AU  - Ranjan A
AU  - Ramsey JD
PY  - 2026
JO  - International journal of pharmaceutics
DO  - 10.1016/j.ijpharm.2026.127194
UR  - https://doi.org/10.1016/j.ijpharm.2026.127194
ER  -

APA

S, M., N, F., A, S., A, H., A, E., S, M., A, R., & JD, R. (2026). Targeted intracellular glucose oxidase nanotherapy enables single-dose treatment of prostate cancer.. International journal of pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127194

Source records

pubmed · retrieved 2026-09-27T00:23:27.976Z